U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060716) titled 'Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring' on June 02.
Brief Summary: The goal of this observational study is to learn if the donor-derived cell-free DNA (dd-cfDNA) test can assess rejection in kidney transplant recipients. Participants will have blood and urine collected at their study visit.
Researchers will compare results of the GraftAssureDx to rejection detected by standard-of-care graft biopsies.
Study Start Date: July 10
Study Type: OBSERVATIONAL
Condition:
Kidney Transplant Rejection
Cell-free DNA
Intervention:
DIAGNOSTIC_TEST: donor-derived cell-free DNA test
A donor-deri...